Strokecopilot: A Precision Medicine Tool in the Stroke Emergency
Strokecopilot
1 other identifier
observational
10,000
1 country
1
Brief Summary
Ischemic stroke or cerebral infarction (CI) is an immediate emergency affecting approximately 100,000 - 150,000 patients each year in France and is managed in the neurovascular intensive care unit (NICU). Recanalization treatments can prevent disability, but patients must be carefully selected. Knowledge in this field is evolving rapidly, which tends to make management more complex and personalized. In addition, the permanence of thrombolysis channels involves neurologists of all expertise. Decision support tools are desirable to enable precision medicine in stroke. Strokecopilot is a web application developed by the principal investigator. Its algorithm contextualizes the patient in a set of evidence-based medicine references (recommendations and clinical trials) and gives the result of their cross-referencing to the user to indicate theoretical indications for intravenous thrombolysis and mechanical thrombectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 10, 2022
CompletedFirst Submitted
Initial submission to the registry
September 2, 2022
CompletedFirst Posted
Study publicly available on registry
September 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedDecember 13, 2023
December 1, 2023
1.6 years
September 2, 2022
December 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retrospective analysis of thrombolysis data for the development of an algorithm to detect thrombolysis
Files analysed retrospectively from January 01, 2017 to December 31, 2021 will be examined
Eligibility Criteria
Adult patient (\>18 years old) admitted to the thrombolysis unit of the University Hospital of Strasbourg
You may qualify if:
- \- Adult patient (\>18 years old) admitted to the thrombolysis unit of the University Hospital of Strasbourg from January 01, 2017 to December 31, 2021
You may not qualify if:
- \- Subjects who have expressed their opposition to the use of their data for scientific research purposes.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service : Unité Neurovasculaire - CHU de Strasbourg - France
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Valérie WOLFF, MD, PhD
Service : Unité Neurovasculaire - CHU de Strasbourg - France
- PRINCIPAL INVESTIGATOR
Stanislas DEMUTH, MD
Service : Unité Neurovasculaire - CHU de Strasbourg - France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2022
First Posted
September 9, 2022
Study Start
May 10, 2022
Primary Completion
December 1, 2023
Study Completion
December 31, 2023
Last Updated
December 13, 2023
Record last verified: 2023-12